Clarify Health delivers advanced analytics that empower provider, payer and life science organizations to optimize patient care and clinical trials. Our platform seamlessly integrates clinical, medical, prescription, social determinants of health and lab data on more than 200 million lives. Leveraging powerful, financial-grade technology, Clarify’s solutions generates actionable insights designed to accelerate clinical trial site selection, define the clinical and economic benefits of therapies at scale, and enhance decision making across product portfolios.
Truly actionable insights are hard to come by. They’re derived from a combination of real-world information, evidence, and experience—not just data. Deloitte’s ConvergeHEALTH suite of software solutions brings together all of these. Our tools reflect the conviction that every patient encounter presents a learning opportunity that can lead to greater efficiency, more patient engagement, and higher-quality care. Informed by our vast experience helping clients transform their enterprises, our applied analytics solutions are developed by, with, and for life science and health care innovators who are leading the data-driven, evidence-based transformation of health care.
OM1 is a health outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes. OM1’s real world evidence platforms, clinical registries and AI technologies enable clients to accelerate research, measure and benchmark health outcomes and to personalize patient care.
Premier Applied Sciences® (PAS) is the research and analytics division of Premier Inc., a leading healthcare improvement company, uniting an alliance of more than 4,000 U.S. hospitals and health systems and approximately 165,000 other providers and organizations to transform healthcare. PAS is leading efforts to improve the outcomes of patients in all disease areas, including oncology, by forging large scale alliances, accelerating value through evidence and translating evidence into practice. Our best-in-class, HIPAA-compliant database from more than 1,000 hospitals contains over 950 million individual patient encounters from more than 220 million unique patients.
Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit